Ekso Bionics Holdings Inc (NASDAQ:EKSO)’s traded shares stood at 0.6 million during the last session, with the company’s beta value hitting 1.47. At the close of trading, the stock’s price was $0.65, to imply a decrease of -5.72% or -$0.04 in intraday trading. The EKSO share’s 52-week high remains $2.50, putting it -284.62% down since that peak but still an impressive 23.08% since price per share fell to its 52-week low of $0.50. The company has a valuation of $14.33M, with an average of 5.53 million shares in intraday trading volume over the past 10 days and average of 1.00 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Ekso Bionics Holdings Inc (EKSO), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give EKSO a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.
Ekso Bionics Holdings Inc (NASDAQ:EKSO) trade information
After registering a -5.72% downside in the last session, Ekso Bionics Holdings Inc (EKSO) has traded red over the past five days. The 5-day price performance for the stock is -17.43%, and 1.81% over 30 days. With these gigs, the year-to-date price performance is 6.80%. Short interest in Ekso Bionics Holdings Inc (NASDAQ:EKSO) saw shorts transact 0.24 million shares and set a 1.41 days time to cover.
The extremes give us $2 and $2 for target low and target high price respectively. As such, EKSO has been trading -207.69% off suggested target high and -207.69% from its likely low.
Ekso Bionics Holdings Inc (EKSO) estimates and forecasts
Looking at statistics comparing Ekso Bionics Holdings Inc share performance against respective industry, we note that the company has outperformed competitors. Ekso Bionics Holdings Inc (EKSO) shares are -49.88% down over the last 6 months, with its year-to-date growth rate higher than industry average at 56.36% against 15.00%. The rating firms project that company’s revenue will shrink -2.24% compared to the previous financial year.
Revenue forecast for the current quarter as set by 2 analysts is 5.05M. Meanwhile, for the current quarter, a total of 2 analyst(s) estimate revenue growth to 4.8M.Earnings reports from the last fiscal year show that sales brought in 4.85M and 3.76M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 4.19% before jumping 27.80% in the following quarter.
EKSO Dividends
Ekso Bionics Holdings Inc has its next earnings report out in February. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Ekso Bionics Holdings Inc (NASDAQ:EKSO)’s Major holders
Ekso Bionics Holdings Inc insiders hold 7.91% of total outstanding shares, with institutional holders owning 25.25% of the shares at 27.42% float percentage. In total, 25.25% institutions holds shares in the company, led by KENT LAKE CAPITAL LLC. As of 2024-06-30, the company held over 0.7 million shares (or 3.9959% of shares), all amounting to roughly $0.73 million.
The next major institution holding the largest number of shares is VANGUARD GROUP INC with 0.59 million shares, or about 3.4125% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $0.63 million.
We also have Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Ekso Bionics Holdings Inc (EKSO) shares. Going by data provided on Sep 30, 2024 , Vanguard Total Stock Market Index Fund holds roughly 400.89 shares. This is just over 1.82% of the total shares, with a market valuation of $0.26 million. Data from the same date shows that the other fund manager holds a little less at 179.46, or 0.82% of the shares, all valued at about 0.12 million.
